Poolbeg Pharma

(POLB)
Sector: Pharmaceuticals & Biotechnology
8.82p
-0.28p -3.08
Last updated: 16:57:08

Director dealings

Trade date Director Volume / Price Trade value Trade type
21/02/2024 Jeremy Skillington 154,764 @ 10.80p £16,714.51 Buy
19/02/2024 Cathal Friel 830,000 @ 11.68p £96,944.00 Buy
05/10/2022 Jeremy Skillington 718,733 @ 4.78p £34,355.44 Buy

Director shareholdings

Name Holding Percent
Cathal Friel 37,219,757 7.00%
Ian O'Connel 8,326,839 1.00%
Jeremy Skillington 1,028,261 0.00%

Major shareholders

Institution name Holding Percent
Michael Kelly 30,876,634 6.18%
Schroder Investment Management 24,994,777 5.00%